author-photo

Martha M. Eibl

Stanford University

78

Papers

1634

Citations

Citation Trend

Filter By

Papers (53) Sort By

Journal Conference Others

Oral direct-acting antiviral therapy for hepatitis C virus infection in X-linked agammaglobulinemia

2019 The Journal of Allergy and Clinical Immunology: In Practice
Show All
- Source
- Cite
- Save
Citations (0)
Vasculitis as a major morbidity factor in patients with hypomorphic RAG mutations

2019 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivo

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (2)
Hypomorphic Mutations in the BCR Signalosome Lead to Selective Immunoglobulin M Deficiency and Impaired B-cell Homeostasis

2018 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (5)
Terminal 14q32.33 deletion as a novel cause of agammaglobulinemia

2017 Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial

2016 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (17)
Genotypic and phenotypic analysis of clinical isolates of Staphylococcus aureus revealed production patterns and hemolytic potentials unlinked to gene profiles and source

2016 BMC Microbiology
Show All
- Source
- Cite
- Save
Citations (22)
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.

2015 Immunotherapy
- Martha M. Eibl
- Hermann M. Wolf
Show All
- Source
- Cite
- Save
Citations (42)
Detection of Impaired IgG Antibody Formation Facilitates the Decision on Early Immunoglobulin Replacement in Hypogammaglobulinemic Patients

2015 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (18)
Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.

2014 Toxins
Show All
- Source
- Cite
- Save
Citations (7)